In 2009, biotech startup 23andMe gained significant momentum with backing from venture capitalists ready to invest in its novel approach to personal genomics. Co-founded by Anne Wojcicki, the company encouraged individuals to explore their genetic makeup through accessible testing methods. As early...

Read More...